Seattle, WA, United States of America

Susan D Holderman


Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 126(Granted Patents)


Location History:

  • Kirkland, WA (US) (1999 - 2007)
  • Seattle, WA (US) (1998 - 2009)

Company Filing History:


Years Active: 1998-2009

Loading Chart...
8 patents (USPTO):Explore Patents

Title: **Innovator Spotlight: Susan D. Holderman**

Introduction

Susan D. Holderman is a prominent inventor based in Seattle, WA, and has made significant contributions to the fields of biotechnology and molecular biology. With a total of eight patents to her name, her innovative work primarily focuses on developing methods and compositions related to nucleic acids and peptide applications in therapeutics.

Latest Patents

Among her latest patents, Holderman has developed an "Isolated nucleic acid sequence comprising SEQ ID NO: 14" which outlines methods utilizing Zven1 and Zven2 polypeptides. These polypeptides are designed to enhance chemokine production and are utilized in treating intestinal motility disorders while improving gastrointestinal function.

Furthermore, another of her notable patents revolves around "FGF homologs and antibodies thereto." This invention includes antibodies and fragments that pertain to zFGF5, a novel member of the fibroblast growth factor family. The associated polypeptides and their encoding polynucleotides demonstrate the potential to proliferate muscle cells, especially cardiac cells, which is vital for cardiac tissue remodeling and improving overall cardiac function.

Career Highlights

Holderman's career has been marked by her dynamic role at Zymogenetics, Inc., where she has leveraged her expertise to drive innovative solutions in the biotech landscape. Her research contributions have been recognized industry-wide, underscoring her status as a leader in her field.

Collaborations

Throughout her career, Susan has collaborated with notable professionals such as Theresa A. Deisher and Darrell C. Conklin. These collaborations have been instrumental in furthering her research and enhancing the practical applications of her inventions.

Conclusion

Susan D. Holderman's work exemplifies the frontier of innovation in biotechnology. Her eight patents reflect her dedication and substantial impact on improving human health through scientific advancements. As she continues her research and development endeavors, her contributions promise to lead to further breakthroughs in the treatment of various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…